Medisystems

Feb 25, 2019

| Source: B. Braun Medical Inc.--US BETHLEHEM, Pa., Feb. 25, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. is pleased to announce the acquisition of the Medisystems® Streamline® Bloodlines business. The acquired bloodline systems will include the Streamline Bloodline for the Dialog+® hemodialysis system, Streamline Bloodline for the Fresenius Medical Care hemodialysis system, and Streamline Bloodline Long for the Fresenius Medical Care hemodialysis system. Sam Amory, Vice President of B. Braun Medical’s Avitum Division said, “We are pleased to add the Streamline bloodline to our dialysis product portfolio. Although we have been selling Streamline for many years, this acquisition will allow us to more broadly promote Streamline’s benefits as part of our transformative system of products, which includes the Dialog® hemodialysis machine and the Diacap® PRO dialyzer.” The inclusion of Streamline Bloodlines is one more addition to the complete integrated line of dialysis products B. Braun’s Avitum division currently offers. To learn more about the full line of available products B. Braun offers for hemodialysis visit www.bbraunusa.com/en/products-and-therapies/renal-therapies/hemodialysis.html. About B. Braun  B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and compounding, ostomy and wound care, and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®. Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com . Allison Longenhagen